QLABOL

Showing posts with the label blood

Global Blood Therapeutics Facebook

March 15, 2022 Post a Comment

NASDAQGBT went down by -402 from its latest closing price compared to the recent 1-year high of 83… Read more

November 25, 2021 Post a Comment

Operator instructions I would now like to turn the call over to Steven Immergut. External links ar… Read more

October 24, 2021 Post a Comment

Global Blood Therapeutics GBT came out with a quarterly loss of 097 per share versus the Zacks Con… Read more

October 12, 2021 Post a Comment

Global Blood Therapeutics sells one drug that treats sickle cell disease and its developing anothe… Read more

September 24, 2021 Post a Comment

GBT Global Blood Therapeutics GBT announced plans to expand the potential use of Oxbryta for the t… Read more

September 22, 2021 Post a Comment

34 rows Global Blood Therapeutics Inc. Has reached its limit for free report views. New Sickle C… Read more

August 11, 2021 Post a Comment

Global Blood Therapeutics GBT is a biopharmaceutical company dedicated to the discovery developmen… Read more

August 01, 2021 Post a Comment

The firm currently has a buy rating on the stock. Furthermore the company is conducting clinical t… Read more